Effects of gender-affirming hormones on lipid, metabolic, and cardiac surrogate blood markers in transgender persons
- Author
- Justine Defreyne (UGent) , Laurens Van de Bruaene, Ernst Rietzschel (UGent) , Judith Van Schuylenbergh (UGent) and Guy T'Sjoen (UGent)
- Organization
- Keywords
- INTRAMUSCULAR TESTOSTERONE UNDECANOATE, TO-MALE TRANSSEXUALS, QUALITY-OF-LIFE, CARDIOVASCULAR RISK-FACTORS, HIGH-DENSITY-LIPOPROTEIN, CORONARY-HEART-DISEASE, CROSS-SEX HORMONES, FOLLOW-UP, ARTERIAL STIFFNESS, VENOUS THROMBOEMBOLISM
Downloads
-
(...).pdf
- full text (Published version)
- |
- UGent only
- |
- |
- 193.74 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8652720
- MLA
- Defreyne, Justine, et al. “Effects of Gender-Affirming Hormones on Lipid, Metabolic, and Cardiac Surrogate Blood Markers in Transgender Persons.” CLINICAL CHEMISTRY, vol. 65, no. 1, 2019, pp. 119–34, doi:10.1373/clinchem.2018.288241.
- APA
- Defreyne, J., Van de Bruaene, L., Rietzschel, E., Van Schuylenbergh, J., & T’Sjoen, G. (2019). Effects of gender-affirming hormones on lipid, metabolic, and cardiac surrogate blood markers in transgender persons. CLINICAL CHEMISTRY, 65(1), 119–134. https://doi.org/10.1373/clinchem.2018.288241
- Chicago author-date
- Defreyne, Justine, Laurens Van de Bruaene, Ernst Rietzschel, Judith Van Schuylenbergh, and Guy T’Sjoen. 2019. “Effects of Gender-Affirming Hormones on Lipid, Metabolic, and Cardiac Surrogate Blood Markers in Transgender Persons.” CLINICAL CHEMISTRY 65 (1): 119–34. https://doi.org/10.1373/clinchem.2018.288241.
- Chicago author-date (all authors)
- Defreyne, Justine, Laurens Van de Bruaene, Ernst Rietzschel, Judith Van Schuylenbergh, and Guy T’Sjoen. 2019. “Effects of Gender-Affirming Hormones on Lipid, Metabolic, and Cardiac Surrogate Blood Markers in Transgender Persons.” CLINICAL CHEMISTRY 65 (1): 119–134. doi:10.1373/clinchem.2018.288241.
- Vancouver
- 1.Defreyne J, Van de Bruaene L, Rietzschel E, Van Schuylenbergh J, T’Sjoen G. Effects of gender-affirming hormones on lipid, metabolic, and cardiac surrogate blood markers in transgender persons. CLINICAL CHEMISTRY. 2019;65(1):119–34.
- IEEE
- [1]J. Defreyne, L. Van de Bruaene, E. Rietzschel, J. Van Schuylenbergh, and G. T’Sjoen, “Effects of gender-affirming hormones on lipid, metabolic, and cardiac surrogate blood markers in transgender persons,” CLINICAL CHEMISTRY, vol. 65, no. 1, pp. 119–134, 2019.
@article{8652720,
author = {{Defreyne, Justine and Van de Bruaene, Laurens and Rietzschel, Ernst and Van Schuylenbergh, Judith and T'Sjoen, Guy}},
issn = {{0009-9147}},
journal = {{CLINICAL CHEMISTRY}},
keywords = {{INTRAMUSCULAR TESTOSTERONE UNDECANOATE,TO-MALE TRANSSEXUALS,QUALITY-OF-LIFE,CARDIOVASCULAR RISK-FACTORS,HIGH-DENSITY-LIPOPROTEIN,CORONARY-HEART-DISEASE,CROSS-SEX HORMONES,FOLLOW-UP,ARTERIAL STIFFNESS,VENOUS THROMBOEMBOLISM}},
language = {{eng}},
number = {{1}},
pages = {{119--134}},
title = {{Effects of gender-affirming hormones on lipid, metabolic, and cardiac surrogate blood markers in transgender persons}},
url = {{http://doi.org/10.1373/clinchem.2018.288241}},
volume = {{65}},
year = {{2019}},
}
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: